Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07528846 · ClinicalTrials.gov registry record · NA

Justice Community Overdose Innovation Network II TCU Hub

A NA study, sponsored by Texas Christian University.

Not yet
Registry status
NA
Development phase
1,620
Enrollment target

NCT07528846: Clinical Trial NA study, sponsored by Texas Christian University.

NCT07528846 is a NA study that has not yet begun recruiting, run by Texas Christian University. The registered enrollment target is 1,620 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07528846, a NA study, has not yet begun recruiting, sponsored by Texas Christian University.

NOT YET RECRUITING
Registry status
NA
Development phase
1,620 participants
Enrollment target

Study Summary

The current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\] and public safety outcomes (e.g., drug-related arrests) associated with Deflection and Pre-Arrest Diversion initiatives (DPAD, hereafter referred to as Deflection); and 2) Create a lasting contribution to the fields of research focused on SU and the criminal legal system (CLS) by advancing knowledge of effective implementation strategies involving the critical role of community engagement in Deflection. The highly experienced team of Multiple PIs, senior-level collaborators from both Deflection and Community Behavioral Health (CBH), state-level evaluation partners, a national stakeholder advisory group, and CLS and behavioral health partners within each community have teamed up to carry out the proposed project. The study approach uses a hybrid implementation-effectiveness design to examine strategies to improve opioid and stimulant relevant outcomes, and specifically proposes to test the implementation-effectiveness of 2 strategy bundles to promote Deflection models through a CORE community engagement bundle (designed to facilitate community stakeholder engagement) and ENHANCED community engagement bundle (CORE plus a component to systematically involve community advocates) on improving implementation as well as public safety and health outcomes. The proposed randomized control trial includes a total of 20 geographically distinct clinical research performance sites (i.e., 20 communities spanning 5 states; New Mexico, Illinois, Wisconsin, Colorado, and Pennsylvania), with 3-5 communities per state and the inclusion of key CLS and CBH stakeholders within each site. The large scope of the project will maximize potential generalizability of study results and sustainability of implementation strategies.

Primary Outcome

Is there a change in public health and safety collaboration? Measured using the Brewer et al., 2018 survey on aligning strategy (e.g., work together to identify unmet needs in the community) and coordinating current work (e.g., share information that helps the system of care work better). The Brewer et al. (2018) Aligning Strategy and Coordinating Work Survey is measured on a 5-point Likert scale, and scores are computed by averaging all items within each scale to yield a mean. Higher scores = s

Interventions

  • OTHER Core-interagency community engagement approach
  • OTHER Enhanced-Core plus community engagement specialist

Trial Details

FieldValue
Enrollment Target 1,620 participants
Start Date 2026-07
Est. Completion 2029-05
Phase NA
Texas Christian University

26 total trials

What is known before NCT07528846 opens enrollment

NCT07528846 is an interventional study that assigns participants to a tested intervention. Its 1,620 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher).

The record links to 0 conditions, and to 2 interventions - of which Core-interagency community engagement approach is the first listed.

NCT07528846 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07528846 about?

NCT07528846 is a clinical study titled "Justice Community Overdose Innovation Network II TCU Hub". The current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\] and public safety outcomes (e.g., drug-rela...

What is the current status of trial NCT07528846?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,620 participants. The study started on 2026-07. Estimated completion is 2029-05.

What interventions are being tested in trial NCT07528846?

The interventions under investigation include: Core-interagency community engagement approach (OTHER), Enhanced-Core plus community engagement specialist (OTHER).

Who is sponsoring clinical trial NCT07528846?

This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07528846's enrollment target sits among peer trials

1,620 63rd of 2000 higher than 1,938 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06959524 · 1,616 participants · NA

    AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  • NCT06271590 · 1,605 participants · NA

    MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

  • NCT00646022 · 1,600 participants

    Natural History of Familial Carcinoid Tumor

  • NCT03109197 · 1,600 participants

    Sudden Unexplained Death in Childhood (SUDC) Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07528846, the US trial registry maintained by the National Library of Medicine. NCT07528846 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.